The global bacteriophage market is experiencing a resurgence in interest and investment, driven by the urgent need for alternative antimicrobial solutions in the face of rising antibiotic resistance. As we dissect the market across different regions—Asia-Pacific, Europe, North America, and the Middle East and Africa—it becomes evident that each region presents unique...